The FDA approved olopatadine hydrochloride and mometasone furoate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis in adults and children aged 12 years and older, according to a press release.
Dr. Srinivas Kota has spent more than 20 years serving patients in the Bolingbrook, Illinois area. Dr. Kota is board certified in internal medicine.